Banking on Insight

Leerink Swann's Investment Banking group possesses an intimate understanding of healthcare and capital markets, and is supported by exclusive insights from MEDACorp. This deep domain knowledge uniquely enables Leerink Swann to initiate strategic business relationships between companies, and to match companies with key healthcare investors.

Having built one of the largest, fully vetted, in-house network of healthcare professionals, our philosophy is simple: Better information leads to better advice.

Our exclusive access to MEDACorp equips our bankers with real-time healthcare insights that are critical to successfully representing our clients on equity and M&A transactions.

Banking relationships begin by developing a deep understanding of corporate clients and their businesses. Armed with that knowledge, our banking team employs an unequaled range of services from our institutional and MEDACorp platforms to ensure that each transaction is effectively positioned for our clients.

To see examples of our success, view a list of recent client transactions.

To read about our insights on the state of healthcare dealflow as featured in Mergers & Acquisitions,
click here.

Our investment bankers have a deep expertise in financing each client's strategic growth through:

• M&A Advisory
• Public Offerings
• PIPEs/RDOs
• Private Placements

Please feel free to contact our investment bankers directly:

Head of Investment Banking
Jim Boylan

Biopharmaceuticals
Dan Dubin, M.D.
Tony Gibney
Bryan Giraudo
Rene Mora, M.D., Ph.D.

Medical Devices
Jed Cohen

Mergers and Acquisitions
Dan Lepanto

Equity Capital Markets - Public
Rahul Chaudhary

Equity Capital Markets - Private
Donald Notman

Tools and Diagnostics
Frank Stokes